Illumina Inc (NAS:ILMN)
$ 146.17 -1.45 (-0.98%) Market Cap: 23.18 Bil Enterprise Value: 25.15 Bil PE Ratio: 0 PB Ratio: 10.87 GF Score: 80/100

Illumina Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 04:55PM GMT
Release Date Price: $150.42 (-2.28%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Hey, everyone. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. It's my pleasure to host Illumina today. And from the company, we have Joydeep Goswami, CFO; and Salli Schwartz, Head of Investor Relations. Welcome, guys.

Joydeep Goswami
Illumina, Inc. - CFO, Chief Strategy & Corporate Development Officer

Thank you.

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So maybe to kick things off, Joydeep, big news last week with Jacob Thaysen's appointment as CEO. This pick seems to signal a fresh start for Illumina with a renewed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot